Cargando…

Editorial: New frontiers in “bladder sparing” treatments for high risk NMIBC

Detalles Bibliográficos
Autores principales:	Hurle, Rodolfo, Lazzeri, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875292/ https://www.ncbi.nlm.nih.gov/pubmed/36713569 http://dx.doi.org/10.3389/fonc.2022.1118940

Ejemplares similares

Comprehensive Gene Expression Analysis in NMIBC Using RNA-seq Reveals New Therapy Strategies
por: Chen, Xiaoliang, et al.
Publicado: (2019)

Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial
por: Contieri, Roberto, et al.
Publicado: (2022)

Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study
por: Fasulo, Vittorio, et al.
Publicado: (2022)

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscleinvasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette- Guérin (BCG): results of an international individual patient data survey (IPDS)
por: Witjes, J Alfred, et al.
Publicado: (2013)

Frontiers in Bladder Cancer Genomic Research
por: Li, Yi, et al.
Publicado: (2021)

The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M
por: Sun, Jian-Xuan, et al.
Publicado: (2023)

Editorial: Fertility-preserving and fertility-sparing treatment approaches in gynecologic malignancies
por: Raimondo, Diego, et al.
Publicado: (2023)

Intravesical ICIs to reduce toxicity in NMIBC
por: Masone, Maria Chiara
Publicado: (2022)

Gene mutation detection of urinary sediment cells for NMIBC early diagnose and prediction of NMIBC relapse after surgery
por: Zhu, Feng, et al.
Publicado: (2019)

Outcomes of BCG Induction in High-Risk Non-Muscle-Invasive Bladder Cancer Patients (NMIBC): A Retrospective Cohort Study
por: Pirzada, Muhammad T, et al.
Publicado: (2017)

Editorial: Intraoperative Radiotherapy (IORT)—A New Frontier for Personalized Medicine as Adjuvant Treatment and Treatment of Locally Recurrent Advanced Malignancy
por: Thomas, Tarita O., et al.
Publicado: (2018)

Back-Splicing Transcript Isoforms (Circular RNAs) Affect Biologically Relevant Pathways and Offer an Additional Layer of Information to Stratify NMIBC Patients
por: Goel, Anshita, et al.
Publicado: (2020)

Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC)
por: Bilim, Vladimir, et al.
Publicado: (2022)

Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study
por: Hurle, Rodolfo, et al.
Publicado: (2020)

Association between radiotherapy and prognosis in patients with small cell carcinoma of the bladder undergoing bladder-sparing surgery
por: Liang, Fuchao, et al.
Publicado: (2023)

Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)
por: Musat, Mihaela Georgiana, et al.
Publicado: (2022)

Editorial: Glycosylation Changes in Cancer: An Innovative Frontier at the Interface of Cancer and Glycobiology
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2016)

Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020)

BCG instillation versus radical cystectomy for high-risk NMIBC with squamous/glandular histologic variants
por: Suh, Jungyo, et al.
Publicado: (2019)

The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population
por: Liu, Shenghua, et al.
Publicado: (2015)

The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC)
por: Rezaee, Michael E., et al.
Publicado: (2020)

Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment
por: Murphy, Anthony J., et al.
Publicado: (2022)

The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study
por: Zhou, Zhongbao, et al.
Publicado: (2021)

Editorial: Biology and treatment of high-risk CLL
por: Tausch, Eugen, et al.
Publicado: (2023)

New Frontiers for the Cytoskeletal Protein LASP1
por: Butt, Elke, et al.
Publicado: (2018)

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology
por: Corbetta, Marinella, et al.
Publicado: (2021)

Editorial: Tumor microenvironment in bladder cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2023)

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
por: Stockem, C.F., et al.
Publicado: (2023)

Editorial: New frontiers in radiobiology
por: Ebner, Daniel K., et al.
Publicado: (2023)

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
por: Nicklas, André P., et al.
Publicado: (2018)

External validation of European Association of Urology NMIBC risk scores to predict progression after transurethral resection of bladder tumor in Korean patients with non-muscle-invasive bladder cancer
por: Kim, Jae Yeon, et al.
Publicado: (2022)

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
por: Lazzeri, Massimo, et al.
Publicado: (2022)

Editorial: Identifying novel biomarkers in bladder cancer
por: Ecke, Thorsten H., et al.
Publicado: (2023)

Editorial: Radical cystectomy in bladder cancer patients
por: Koshkin, Vadim S., et al.
Publicado: (2022)

Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
por: Ripping, Theodora M., et al.
Publicado: (2021)

NBI cystoscopy and bipolar electrosurgery in NMIBC management – An overview of daily practice
por: Geavlete, B, et al.
Publicado: (2013)

Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis
por: Del Giudice, Francesco, et al.
Publicado: (2022)

Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)
por: Broughton, Edward I., et al.
Publicado: (2022)

CircRNAs in Malignant Tumor Radiation: The New Frontier as Radiotherapy Biomarkers
por: Wu, Xixi, et al.
Publicado: (2022)

Editorial: Parental mentalization: New frontiers
por: Kalland, Mirjam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nfe1mablclibidgnm45476c3mc